Tumor Biomarker Association With Clinical Outcomes in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Patients (Pts) Treated With Afatinib Versus Methotrexate (MTX): LUX-Head & Neck 1 (LHN1). - Cohen, E.; Licitra, L.; Burtness, B.; Fayette, J.; Gauler, T.; Clement, P.M.; Grau, J.J.; del Campo, J.M.; Mailliez, A.; Haddad, R.I.; Vermorken, J.B.; Tahara, M.; et al. (International Journal of Radiation Oncology, Biology, Physics, 2016)